After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

Cutting-edge research explores how social robots and AI can revolutionize dementia care by detecting early signs of cognitive ...

Too often as patients age, doctors pile on prescriptions. The practice, known as polypharmacy, can be dangerous at any age but is particularly hazardous for elderly people, from raising the risk of ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

A different 2021 study found that treating the eye conditions increasing a person’s risk of dementia could actually reverse ...

The research indicated that those with cataracts and systemic conditions were up to 2.29 times more likely to develop ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease ...

A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.